Afuco™ Anti-Human CSF1 ADCC Theraputic Antibody (PD-0360324), ADCC Enhanced

Product sourcing details

Place of Origin
USA

Supplier: Creative Biolabs

Purchasing information

Minimum order
1
Lead time
15 Days

Please confirm with the supplier: Model / reference, Key specifications / compatibility, Samples, Export markets, Supply capacity.

Anti-CSF1 ADCC Enhanced Antibody (PD-0360324) is an ADCC enhanced antibody produced by our Afuco™ platform. This is a novel neutralizing human monoclonal antibody against monocyte/ macrophage colony stimulating factor (M-CSF). It exhibited a nonlinear PK profile associated with rapid suppression of PD markers and was generally well tolerated. The safety and efficacy profile will be investigated further in a multi-dose study in patients with rheumatoid arthritis.
https://www.creativebiolabs.net/Anti-CSF1-ADCC-Enhanced-Antibody-PD-0360324-20483.htm
  • Company: Creative Biolabs
  • Country: United States
  • Founded Year: 2005
  • Contact: Jerry Carter

Creative Biolabs

Enter between 20 to 3,000 characters. English only. Characters: 0 / 3000
submiting now We do inquire for you, please wait...